T. V. Rakitina, A. A. Zeifman, F. N. Novikov, O. V. Stroganov, V. S. Stroylov, I. Svitanko, A. Frank-Kamenetskii, G. G. Chilov, “Novel PARP1 inhibitors potentiate doxorubicin antitumor activity in vitro”, Mendeleev Commun., 25:5 (2015), 364

Mendeleev Communications

RUS ENG

JOURNALS PEOPLE ORGANISATIONS CONFERENCES SEMINARS VIDEO LIBRARY PACKAGE AMSBIB

JavaScript is disabled in your browser. Please switch it on to enable full functionality of the website

	General information
	Latest issue
	Archive

	Search papers
	Search references

	RSS
	Latest issue
	Current issues
	Archive issues
	What is RSS

Mendeleev Commun.:
Year:
Volume:
Issue:
Page:
	Find

Personal entry:
Login:
Password:
	Save password
	Enter
	Forgotten password?
	Register

Mendeleev Communications, 2015, Volume 25, Issue 5, Pages 364–366
DOI: https://doi.org/10.1016/j.mencom.2015.09.016 (Mi mendc2410)

This article is cited in 3 scientific papers (total in 3 papers)

Communications

Novel PARP1 inhibitors potentiate doxorubicin antitumor activity in vitro

T. V. Rakitina^ab, A. A. Zeifman^c, F. N. Novikov^c, O. V. Stroganov^c, V. S. Stroylov^c, I. Svitanko^cd, A. Frank-Kamenetskii^a, G. G. Chilov^c

^a National Research Centre 'Kurchatov Institute', Moscow, Russian Federation
^b M.M. Shemyakin–Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation
^c N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation
^d Department of Chemistry, M.V. Lomonosov Moscow State University, Moscow, Russian Federation

Full-text PDF (305 kB) Citations (3)

DOI: https://doi.org/10.1016/j.mencom.2015.09.016

Graphic abstract: Novel PARP1 inhibitors potentiate doxorubicin antitumor activity in vitro

Abstract: Six novel potential PARP1 inhibitors were identified by means of substructure search and molecular docking into PAPR1 active site; one compound (STK970217) potentiated the cytotoxicity of doxorubicin in hepatocellular carcinoma HepG2 cells being non-cytotoxic as a single agent, while three other identified compounds inhibited the growth of HepG2 cells both individually and in combination with doxorubicin.

Bibliographic databases:

Document Type: Article

Language: English

Citation: T. V. Rakitina, A. A. Zeifman, F. N. Novikov, O. V. Stroganov, V. S. Stroylov, I. Svitanko, A. Frank-Kamenetskii, G. G. Chilov, “Novel PARP1 inhibitors potentiate doxorubicin antitumor activity in vitro”, Mendeleev Commun., 25:5 (2015), 364–366

Linking options:

https://www.mathnet.ru/eng/mendc2410

https://www.mathnet.ru/eng/mendc/v25/i5/p364

This publication is cited in the following 3 articles:

Citing articles in Google Scholar: Russian citations, English citations
Related articles in Google Scholar: Russian articles, English articles

Registration to the website

Logotypes